Skip to main content
TipRanks
Go Ultimate75% OFF

Amoeba SA (A1H) AI Stock Analysis

0 Followers
DE:A1H

Amoeba SA

(Frankfurt:A1H)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Proprietary Biotechnology PlatformA proprietary amoeba-based platform gives Amoéba a defined technology foundation across biological solutions. If regulatory development and commercialization progress, the platform could support repeatable product creation and differentiation in bio-based markets.
Negative Factors
Revenue CollapseRevenue falling to zero leaves the business without demonstrated commercial scale and makes near-term financial performance highly dependent on restarting sales. Persistent operating and net losses show that the current cost base is not supported by recurring revenue.

Amoeba SA (A1H) vs. iShares MSCI Germany ETF (EWG)

-80%-60%-40%-20%0%20%DE:A1H-70.87%EWG+1.23%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 35.39M
Dividend Yield
―
Average Volume (3M)
20.89K
Price to Earnings (P/E)
-1.9
Beta (1Y)
0.66
Revenue Growth
―
EPS Growth
-16.71%
Country
Germany
Employees
23
Sector
Healthcare
Sector Strength
51
Industry
Agricultural Inputs

Amoeba SA Business Overview & Revenue Model

Company Description

Amoéba S.A. focuses on the development and commercialization of anti-microbial and anti-fungal products. The company's primary innovation centers on harnessing the unique properties of the Willaertia magna C2c Maky amoeba, which it is applying across...

Amoeba SA Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:A1H against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
FR:COHFR:COH65NeutralEUR 40.71M12.8312.54%1.18%8.58%-18.77%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
FR:ALATAFR:ALATA44NeutralEUR 54.14M-6.20-101.20%―66.67%74.66%
FR:BIGFR:BIG40UnderperformEUR 985.29K-0.00-403.52%―-1.22%-101445.24%
FR:ALCLAFR:ALCLA32UnderperformEUR 29.68M6.1010.38%―――

* Healthcare Sector Average

Performance Comparison

-50%0%50%100%DE:A1HFR:ALJXRFR:ALATAFR:ALCLAFR:BIGFR:COHDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:A1H and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:A1HAmoeba SA0.27-0.69-71.82%
FR:ALJXRArchos0.250.0736.22%
FR:ALATAAtari SA12.70-10.40-45.02%
FR:ALCLAClaranova SA0.49-0.88-64.23%
FR:BIGBigben Interactive0.05-0.95-94.71%
FR:COHCoheris6.80-7.41-52.14%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.